Integrative -omics and HLA-ligandomics analysis to identify novel drug targets for ccRCC immunotherapy.

Saved in:
Bibliographic Details
Title: Integrative -omics and HLA-ligandomics analysis to identify novel drug targets for ccRCC immunotherapy.
Authors: Reustle, Anna1,2 (AUTHOR), Di Marco, Moreno3 (AUTHOR), Meyerhoff, Carolin1,2 (AUTHOR), Nelde, Annika3,4,5 (AUTHOR), Walz, Juliane S.4,5,6 (AUTHOR), Winter, Stefan1,2 (AUTHOR), Kandabarau, Siahei1,2 (AUTHOR), Büttner, Florian1,2 (AUTHOR), Haag, Mathias1,2 (AUTHOR), Backert, Linus3 (AUTHOR), Kowalewski, Daniel J.3 (AUTHOR), Rausch, Steffen7 (AUTHOR), Hennenlotter, Jörg7 (AUTHOR), Stühler, Viktoria7 (AUTHOR), Scharpf, Marcus8 (AUTHOR), Fend, Falko8 (AUTHOR), Stenzl, Arnulf7 (AUTHOR), Rammensee, Hans-Georg3,5,6 (AUTHOR), Bedke, Jens7 (AUTHOR), Stevanović, Stefan3,5,6 (AUTHOR)
Source: Genome Medicine. 3/30/2020, Vol. 12 Issue 1, p1-24. 24p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:1756994X
DOI:10.1186/s13073-020-00731-8